top of page

Landmark Longevity Summits at King's College London Demonstrate That Top Financial and Tech Corporations Are Committed to Longevity

The Landmark International Longevity Policy, Governance and AI for Longevity Summits, Featuring Presentations and Panels from Top Executives of Prudential, AXA, HSBC, L&G, Microsoft and NVIDIA, Reveal the Future Intersection of AI, Policy, Finance and Longevity


This week two Landmark International Longevity Summits in London attracted the attention of scientists, government officials, major financial corporations, insurance companies, investment banks, and technology companies from around the world. The Landmark AI for Longevity Summit and the First International Longevity Policy and Governance Summit at King's College London are expected to become the world-leading forums for the Longevity Industry.


Longevity for AI Summit


The AI for Longevity Summit featured talks from top executives from Prudential, HSBC, AXA Insurance, NVIDIA, Microsoft, Babylon Health, Insilico Medicine, Longevity.Capital, Longevity Vision Fund, Juvenescence, Deep Knowledge Ventures, and the UK All-Party Parliamentary Group for Longevity. The International Longevity Policy and Governance Summit focused on the efforts of longevity-progressive governments to transform the challenge of rapidly ageing populations into the opportunity of healthy longevity, drawing on experience from Japan, Israel, Switzerland, US, and UK.


The Deep Knowledge Group has developed sophisticated methods for translating advanced AI for Longevity solutions. Together with its subsidiaries, the company has developed advanced frameworks and technologies including novel applications of life data for insurance companies, pension funds, healthcare companies, and government bodies. These new technologies and instruments at the forefront of the rising Longevity Financial Industry provide practical applications of preventive medicine and Precision Health.

Dmitry Kaminskiy, founder of Deep Knowledge Group presented two special analytical case-studies at the Summit. The first entitled Global Longevity Governance: 50 Countries Big Data Comparative Analysis of Longevity Progressiveness featured benchmarking of 50 nations. Researchers from Aging Analytics Agency used 200 parameters per country and 10,000 data points in total to rank 50 countries according to their respective levels of Healthy Longevity. The study revealed gaps between health-adjusted life expectancy and unadjusted life expectancy and provided tangible policy recommendations on how to these nations could optimize their National Healthy Longevity.

International Longevity Policy and Gover


“We need nations to begin to marshal their resources to leverage the opportunities of healthy longevity. What is critical now is to maximize the opportunity of healthy longevity in as socially-inclusive a manner as possible and share the longevity dividend equitably around the world”


- Dmitry Kaminskiy, Director of International Cooperation, Longevity International UK.



Dmitry Kaminskiy also delivered a presentation with highlights from Aging Analytics Agency’s new report entitled Biomarkers of Longevity: Most Comprehensive and Minimum Required Panels of Biomarkers of Aging.


This report utilizes comprehensive analytical frameworks to benchmark biomarkers of aging, health and Longevity using ratios of accuracy vs actionability in order to present a “Minimum Viable Panel” of Longevity biomarkers that are precise enough and immediately implementable in practice. This highlights the increasingly necessary role that AI will play in coordinating the practical implementation of Longevity biomarkers due to the sheer volume of life and health data involved.

International Longevity Policy and Gover


“AI for Longevity is an underrepresented sector in the Longevity Industry despite having more potential to increase healthy Longevity in the short term than any other sector. It is our aim to change that with the launch of the Longevity AI Consortium at King’s College London, which will work to facilitate the shift from treatment to prevention and from preventive medicine to real-world precision health.” - Dmitry Kaminskiy, Managing Partner of Deep Knowledge Group.


Speakers and delegates at the Summit shared learnings from the UK, Japan, Israel and other countries successfully mobilising the opportunities longer lives can bring. International policymakers and major corporate players in finance, insurance, investment, science, pharma and tech exchanged their experiences and ideas on beginning to working together in a new ‘social contract’ to enhance global prosperity equitably.

“Unless drastic action is taken, people will suffer lower quality wellbeing during a longer lifespan. This could become the next global crisis after climate change. The Longevity AI Consortium is unique in its focus on preventive health, addressing the social determinants of health at the root of inequalities.”


- Tina Woods, CEO, Longevity International UK.


The Longevity AI Consortium


The Longevity AI Consortium at King’s College London, which launched this week will work to facilitate the shift from treatment to prevention and from preventive medicine to real-world Precision Heath. Deep Knowledge Ventures has long recognized the importance of this sector, and one of our very first investments was in an AI for Longevity startup in 2014. It remains a large focus of our strategic agenda to this day, and will be one of the most heavily prioritized sectors of the target investment portfolio of our new Longevity-focused hybrid investment fund Longevity.Capital.



“AI holds enormous potential to rapidly accelerate the implementation of Longevity R&D. The nation is home to multiple centres of AI for Healthcare, but not a single Longevity AI Consortium. We are changing this through our unique academic-industry focus on preventive and personalised physical, mental and financial health, marking us out from other AI and Ageing centres around the world”       


- Richard Siow, Ph.D., Director, Longevity AI Consortium, King’s College London.



The initial focus will be on core longevity academic-industry R&D, including the development of biomarkers of aging and novel implementation of life and health data analytics. In 2020, after achieving several key scientific and funding milestones, AI-enabled solutions for physical, mental and financial wellness will become a major focus, and an AI Longevity Accelerator will be launched to serve as a much-needed bridge between start-ups and major UK investors, creating for the first time a dedicated infrastructure for increased investments and developments in this important sector.